Worth clearing up first, since the name invites confusion in an AI-saturated search landscape: GP Tools is a GP appraisal toolkit, not a generic AI or ChatGPT product, and the two should not be conflated when researching either. Its actual proposition is unusually clear once stated plainly, and its comparative lack of independent editorial coverage means most prospective users currently rely on the vendor's own pages to understand it, which is precisely the gap this review exists to fill.
The headline offer
£39.99 a year, with the first twelve months free and no card required to start the trial. Patient questionnaires and multi-source feedback are included in that price rather than sold as an add-on, appraiser accounts are free, and the company states there is no upselling. It presents itself as a complete GP appraisal toolkit built around the NHS England appraisal structure, with mobile and web access, rather than a narrower CPD diary requiring a separate submission platform.
What to check before committing a full year's evidence
Since a portfolio represents genuine professional risk if it fails at the point you need it most, the following are worth testing directly, ideally during the free trial period, rather than assumed from the pricing page alone. Adding CPD entries: how quickly and cleanly the form captures learning and reflection. Adding a QIA: whether the structure matches what your designated body expects. Recording a significant event: the specific fields and governance language used. Creating a PDP: whether objectives carry forward meaningfully year to year. Uploading documents: file types supported and any size limits. Inviting an appraiser: how straightforward the invitation and access process actually is from their side, not only yours. Completing declarations: whether the standard NHS England declaration set is present and current. And producing the final output: what the finished appraisal document actually looks like, and whether it matches the format your appraiser expects to see.
Review the mobile experience separately from the desktop site, since the two frequently diverge in a platform's actual usability regardless of feature-list parity. Examine patient and colleague feedback specifically: how questionnaires are distributed, whether there is a minimum response requirement, how the report is generated, what confidentiality protections exist for respondents, and whether the platform incorporates reflection on the feedback into the appraisal itself rather than leaving it as a standalone attachment. Examine export and data portability directly, and ask specifically whether historic information remains accessible if the subscription lapses, a question worth an explicit answer before you rely on any platform for a multi-year professional record. Compare customer support and help documentation against FourteenFish and Clarity's more established resources, since a smaller, newer platform's support responsiveness matters more, not less, precisely because fewer other users have already encountered and documented the same questions.
The balanced conclusion
GP Tools' price is compelling, particularly because feedback tools that competitors sometimes charge separately for are included in the base subscription. The decisive question for anyone considering a switch is not price alone: it is whether the platform's user experience, its appraiser familiarity relative to the two established incumbents, and its transfer mechanisms are sufficient to offset the genuine network effects FourteenFish and Clarity have built over years of accumulated appraiser and designated-body familiarity. That question is answerable only by testing the platform directly against your own designated body's expectations, not by comparing feature lists alone.
Where this sits in the wider landscape
GP Tools is a full appraisal system of record, in the same category as FourteenFish and Agilio Clarity rather than a learning-capture layer like Umbil, BMJ Portfolio or GPnotebook Pro, the taxonomy this cluster's dedicated pillar comparison sets out in full. That means the honest comparison is against those two established platforms specifically, on price, workflow and appraiser familiarity, not against the learning-layer tools that solve a different problem entirely.
Frequently asked questions
Is GP Tools accepted for GP appraisal by every designated body?
Confirm this directly with your own designated body and appraiser before switching, since acceptance in practice depends on their familiarity with the specific output format, which a newer, lower-profile platform has had less time to establish than FourteenFish or Clarity.
Does the free first year include full feedback functionality?
The published pricing states that patient and colleague feedback tools are included in the standard subscription rather than sold separately, which should apply during the free first year on the same terms, worth confirming directly at signup.
What happens to my portfolio history if I do not renew after the free year?
This is exactly the kind of retention and export question worth confirming explicitly with GP Tools before your first year's evidence accumulates, rather than assumed, since the answer materially affects whether the first free year carries any lock-in risk.